意大利的前性观察性研究,以评估复发性多发性硬化症患者的治疗满意度和有效性,开始服用克拉迪宾片 (CLADREAL)
Massimo Filippi1,2,3,4,5, Laura Ferrè2, Chiara Zanetta1,2
1Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Frontiers in neurology
|April 19, 2024
概括
这项研究评估了对复发性多发性硬化症 (MS) 的克拉德里宾片. 它衡量患者的满意度和生活质量,提供现实世界的数据来指导MS患者的治疗决策.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 疾病修饰疗法 (DMT) 对于治疗多发性硬化症 (MS),减少复发和减缓进展至关重要.
- 关于患者报告结果 (PRO) 和生活质量 (QoL) 的现实数据对于优化DMT选择至关重要.
- 克拉德里宾片,一种免疫复合疗法,在复发性多发性硬化症 (RMS) 中显示出高疗效.
研究的目的:
- 为了前性地评估克拉德里宾片在患有RMS的成年人中的有效性.
- 评估克拉德里宾片对临床和MRI参数的影响,以及各种PROs.
- 主要测量从其他DMT转换为克拉迪宾片的患者治疗满意度的变化.
主要方法:
- 一项观察性研究协议,以前性地评估意大利成年RMS患者的克拉德里宾片.
- 纳入标准:没有接受过治疗或先前接触过有限的DMT.
- 主要终点:在开始治疗后24个月的总体治疗满意度的变化;次要终点包括更早的时间点,以前没有接受过治疗的患者,有效性,耐受性,复发,残疾,MRI和其他PRO在12个月和24个月.
主要成果:
- 这项研究旨在深入了解患者报告的治疗结果和对克拉迪宾片治疗满意度.
- 它将在现实临床环境中量化有效性和耐受性.
- 数据将补充对临床和MRI结果的受控试验发现.
结论:
- 结果将提供有价值的现实世界的洞察力,了解患者对RMS的克拉德里宾片的体验.
- 这些数据将有助于临床医生和患者做出明智的治疗选择.
- 该研究补充了现有证据,重点关注常规实践中的PRO和QOL.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
161
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
161
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
136
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
136
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K


